EcoDrugPlus

Ensembl ID : ENSOMYG00000016737
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSOMYG00000010582
Gene Symbol: -
Cross references: -
331 Possible Orthologues:

Ensembl ID : ENSOMYG00000024793
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSOMYG00000022224
Gene Symbol: -
Cross references: -
53 Possible Orthologues:

Ensembl ID : ENSOMYG00000025020
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSOMYG00000025559
Gene Symbol: -
Cross references: -
301 Possible Orthologues:

Ensembl ID : ENSOMYG00000025729
Gene Symbol: -
Cross references: -
266 Possible Orthologues:

Ensembl ID : ENSOMYG00000026460
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSOMYG00000033405
Gene Symbol: -
Cross references: -
443 Possible Orthologues:

Ensembl ID : ENSOMYG00000026489
Gene Symbol: -
Cross references: -
169 Possible Orthologues:

Ensembl ID : ENSOMYG00000033233
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSOMYG00000026690
Gene Symbol: -
Cross references: -
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).